https://idataresearch.com/wp-content/themes/lambda-child-theme/images/footer-logo.png
https://idataresearch.com/wp-content/themes/lambda-child-theme/images/idata-white-logo.png

Installed Base

Showing all 9 results

Gastrointestinal Endoscopic Devices Market Analysis, Size, Trends | China | 2020-2026 | MedSuite

The Chinese gastrointestinal (GI) endoscopic device market includes GI endoscopes, capsule endoscopes, stenting devices, dilation devices, endoscopic retrograde cholangiopancreatography (ERCP) devices, biopsy forceps, polypectomy snares, hemostasis devices and enteral feeding devices. High demand for GI screening and intervention procedures due to the aging population and growing awareness will drive market growth. Over the 2011–2018 forecast period, market expansion will be fueled by procedural growth and a higher incidence of GI disease; this will result in market growth accelerating gradually over the forecast period.

more...

Virtual Colonoscopy Software Market Report | United States | 2019-2025 | MedCore

Adoption is expected to continue over the forecast period, but unit sales will continue exhibiting negative growth, due to the long lifespan of virtual colonoscopy software. One positive factor that might help counter unit erosion is the relative affordability of colonography against optical colonoscopy. Given the growing costs of colonoscopy screening in the United States,

more...

Gastrointestinal Endoscopic Devices Market Analysis, Size, Trends | Europe | 2019-2025 | MedSuite (Includes 9 Reports)

Overall, the European gastrointestinal endoscopic devices market was valued at nearly €1.2 billion in 2019. This is expected to increase over the forecast period at a CAGR of 2.3% to reach just under €1.4 billion. The saturated nature of the European market for GI endoscopic devices will somewhat limit growth over the forecast period. Reimbursement

more...

Gastrointestinal Endoscopy Devices Market Size, Share & Trends Analysis | Global | 2019-2025 | 3 MedSuites | Includes: Gastrointestinal Endoscopes, Virtual Colonoscopy Software, Capsule Endoscopy, Stenting & Dilation, ERCP, Hemostasis, Enteral Feeding, Anti-Reflux & Barrett’s Esophagus Ablation Devices

This Global Report Series represents iData’s entire collection of country-level reports in the Gastrointestinal (GI) Endoscopy Devices Market. Each of these reports may be purchased as a stand-alone report, tailoring the data to your needs. The covered countries are listed below, including the report’s base year: United States (2019) Europe (2019) China (2020) US Gastrointestinal

more...

Gastrointestinal Endoscopic Devices Market Analysis, Size, Trends | United States | 2019-2025 | MedSuite (Includes 13 reports)

Overall, the U.S. GI endoscopic device market was valued at over $2.9 billion in 2018. This is expected to increase over the forecast period at a CAGR of 3.5% to exceed $3.7 billion. As the demand side of the market continues to undergo consolidation with hospitals acquiring outpatient facilities and expanding the reach of the

more...

Capsule Endoscopy Market Analysis, Size, Trends | Global | 2019-2025 | MedCore

Industry Trends Capsule endoscopy was first introduced in the U.S. in 2001 by Given Imaging, an Israeli company based in Yokneam, Israel. Modeled after advanced missile guidance technology, capsule endoscopy allows patients to undergo diagnostic procedures without any of the discomfort associated with conventional endoscopies. These procedures are noninvasive and typically painless. From 2001 to

more...

Virtual Colonoscopy Market Analysis | United States | 2017-2023 | MedCore

The U.S. market for virtual colonoscopy is defined in this report as virtual colonoscopy software installed on workstations and servers for CT and MRI scanners. The value of the total U.S. market for colonoscopy software decreased in 2016. The negative trend is expected throughout the forecast period and will be driven by the drop in the units sales with slightly positive addition from the ASP. The majority of virtual colonoscopy software units are sold as part of the total software package for workstations to hospitals and outpatients facilities alike. Only a small portion of units are sold as a standalone solution. For the purpose of this report the ASP was calculated based on the price of virtual colonoscopy software as part of the software bundle.

more...

Gastrointestinal Devices Product Portfolio and Pipeline | United States | 2017-2023 | MedFolio

The full report suite on the U.S. market for gastrointestinal (GI) endoscopic devices consists of devices related to GI flexible endoscopy, capsule endoscopy, virtual colonoscopy, eEndoscopic Retrograde retrograde Cholangiopancreatography cholangiopancreatography (ERCP), stenting and dilation, biopsy, specimen and foreign-body removal, hemostasis, enteral feeding, anti-reflux, and Barret’s Esophagus. There are several on-going trends in the GI space such as the expansion of the therapeutic capabilities of the devices fueled by the market desire for the less-invasive treatment options. For example, the stenting and dilation devices that are now used for patients that would have had to undergo surgical intervention in the past. The other emerging trend is related to challenges with the infection control for the GI devices that now are making inroads for growing popularity of the single-use devices, even on the originally capital equipment type of devices such as scopes.

more...

Gastrointestinal Devices Procedure Volume Analysis | United States | 2017-2023 | MedPro

The full report suite on the U.S. market for gastrointestinal (GI) endoscopic devices consists of devices related to GI flexible endoscopy, capsule endoscopy, virtual colonoscopy, eEndoscopic Retrograde retrograde Cholangiopancreatography cholangiopancreatography (ERCP), stenting and dilation, biopsy, specimen and foreign-body removal, hemostasis, enteral feeding, anti-reflux, and Barret’s Esophagus. There are several on-going trends in the GI space such as the expansion of the therapeutic capabilities of the devices fueled by the market desire for the less-invasive treatment options. For example, the stenting and dilation devices that are now used for patients that would have had to undergo surgical intervention in the past. The other emerging trend is related to challenges with the infection control for the GI devices that now are making inroads for growing popularity of the single-use devices, even on the originally capital equipment type of devices such as scopes.

more...